Complement inhibition in a xenogeneic model of interactions between human whole blood and porcine endothelium

Hormone and Metabolic Research

Volumn 47, Issue 1, 2015, Pages 36-42

  Kourtzelis, I ^a   Ferreira, A ^a   Mitroulis, I ^a   Ricklin, D ^b   Bornstein, S R ^a   Waskow, C ^a   Lambris, J D ^b   Chavakis, T ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

complement C3; compstatin; leukocyte adhesion; xenotransplantation

Indexed keywords

CD11B ANTIGEN; CELL ADHESION MOLECULE; COMPLEMENT COMPONENT C3; COMPLEMENT INHIBITOR; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 2; VASCULAR CELL ADHESION MOLECULE 1; COMPLEMENT; COMPLEMENT COMPONENT C5A RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD; COMPLEMENT ACTIVATION; COMPLEMENT INHIBITION; CONTROLLED STUDY; ENDOTHELIUM; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IMMUNITY; LEUKOCYTE; LEUKOCYTE ADHERENCE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; SWINE; UPREGULATION; XENOTRANSPLANTATION; ANIMAL; BIOLOGICAL MODEL; BLOOD CELL; BLOOD CLOTTING; CELL ADHESION; CELL COMMUNICATION; CYTOLOGY; METABOLISM; PIG; XENOGRAFT;

SUIDAE; SUS;

ANIMALS; BLOOD CELLS; BLOOD COAGULATION; CELL ADHESION; CELL ADHESION MOLECULES; CELL COMMUNICATION; COMPLEMENT ACTIVATION; COMPLEMENT C3; COMPLEMENT SYSTEM PROTEINS; ENDOTHELIAL CELLS; ENDOTHELIUM; HUMANS; LEUKOCYTES; MACROPHAGE-1 ANTIGEN; MODELS, BIOLOGICAL; RECEPTOR, ANAPHYLATOXIN C5A; SUS SCROFA; TRANSPLANTATION, HETEROLOGOUS; UP-REGULATION;

EID: 84920749763     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0034-1390452     Document Type: Article

References (56)

1. Cozzi E., Bosio E., Seveso M., Vadori M., Ancona E. Xenotransplantation-current status and future perspectives. Br Med Bull: 2005; 75-76 99 114
2. Pierson R. N., Dorling A., Ayares D., Rees M. A., Seebach J. D., Fishman J. A., Hering B. J., Cooper D. K. Current status of xenotransplantation and prospects for clinical application. Xenotransplantation: 2009; 16 263 280
3. Yang Y-G, Sykes M. Xenotransplantation: current status and a perspective on the future. Nat Rev Immunol: 2007; 7 519 531
4. Schneider MK J., Seebach J. D. Current cellular innate immune hurdles in pig-to-primate xenotransplantation. Curr Opin Organ Transplant: 2008; 13 171 177
5. Cooper D. K. Depletion of natural antibodies in non-human primates-a step towards successful discordant xenografting in humans. Clin Transplant: 1992; 6 178 183
6. Goto M., Tjernberg J., Dufrane D., Elgue G., Brandhorst D., Ekdahl K. N., Brandhorst H., Wennberg L., Kurokawa Y., Satomi S., Lambris J. D., Gianello P., Korsgren O., Nilsson B. Dissecting the instant blood-mediated inflammatory reaction in islet xenotransplantation. Xenotransplantation: 2008; 15 225 234
7. Bennet W., Sundberg B., Groth C. G., Brendel M. D., Brandhorst D., Brandhorst H., Bretzel R. G., Elgue G., Larsson R., Nilsson B., Korsgren O. Incompatibility between human blood and isolated islets of Langerhans: a finding with implications for clinical intraportal islet transplantation? Diabetes: 1999; 48 1907 1014
8. Nilsson B., Ekdahl K. N., Korsgren O. Control of instant blood-mediated inflammatory reaction to improve islets of Langerhans engraftment. Curr Opin Organ Transplant: 2011; 16 620 626
9. Ricklin D., Hajishengallis G., Yang K., Lambris J. D. Complement: a key system for immune surveillance and homeostasis. Nat Immunol: 2010; 11 785 797
10. Huber-Lang M., Sarma J. V., Zetoune F. S., Rittirsch D., Neff T. A., McGuire S. R., Lambris J. D., Warner R. L., Flierl M. A., Hoesel L. M., Gebhard F., Younger J. G., Drouin S. M., Wetsel R. A., Ward P. A. Generation of C5a in the absence of C3: a new complement activation pathway. Nat Med: 2006; 12 682 687
11. Morgan B. P., Berg C. W., Harris C. L. Homologous restriction in complement lysis: roles of membrane complement regulators. Xenotransplantation: 2005; 12 258 265
12. Cowan P. J., d' Apice A. J. Complement activation and coagulation in xenotransplantation. Immunol Cell Biol: 2009; 87 203 208
13. Bongoni A. K., Kiermeir D., Jenni H., Wünsch A., Bähr A., Ayares D., Seebach J. D., Wolf E., Klymiuk N., Constantinescu M. A., Vögelin E., Rieben R. Activation of the lectin pathway of complement in pig-to-human xenotransplantation models. Transplantation: 2013; 96 791 799
14. Dalmasso A. P., Platt J. L., Bach F. H. Reaction of complement with endothelial cells in a model of xenotransplantation. Clin Exp Immunol: 1991; 86 01 31 35
15. Dalmasso A. P., Vercellotti G. M., Platt J. L., Bach F. H. Inhibition of complement-mediated endothelial cell cytotoxicity by decay-accelerating factor. Potential for prevention of xenograft hyperacute rejection. Transplantation: 1991; 52 530 533
16. Huang J., Gou D., Zhen C., Jiang D., Mao X., Li W., Chen S., Cai C. Protection of xenogeneic cells from human complement-mediated lysis by the expression of human DAF, CD59 and MCP. FEMS Immunol Med Microbiol: 2001; 31 203 209
17. Miyagawa S., Mikata S., Shirakura R., Matsuda H., Nagasawa S., Terados A., Hatanaka M., Matsumoto M., Seya T. C5b-8 step lysis of swine endothelial cells by human complement and functional feature of transfected CD59. Scand J Immunol: 1996; 43 361 366
18. Sweigard J. H., Yanai R., Gaissert P., Saint-Geniez M., Kataoka K., Thanos A., Stahl G. L., Lambris J. D., Connor K. M. The alternative complement pathway regulates pathological angiogenesis in the retina. FASEB J: 2014; 28 3171 3182
19. Langer H. F., Chung K-J, Orlova V. V., Choi E. Y., Kaul S., Kruhlak M. J., Alatsatianos M., DeAngelis R. A., Roche P. A., Magotti P., Li X., Economopoulou M., Rafail S., Lambris J. D., Chavakis T. Complement-mediated inhibition of neovascularization reveals a point of convergence between innate immunity and angiogenesis. Blood: 2010; 116 4395 4403
20. Silasi-Mansat R., Zhu H., Popescu N. I., Peer G., Sfyroera G., Magotti P., Ivanciu L., Lupu C., Mollnes T. E., Taylor F. B., Kinasewitz G., Lambris J. D., Lupu F. Complement inhibition decreases the procoagulant response and confers organ protection in a baboon model of Escherichia coli sepsis. Blood: 2010; 116 1002 1010
21. Laudes I. J., Chu J. C., Huber-Lang M., Guo R-F, Riedemann N. C., Sarma J. V., Mahdi F., Murphy H. S., Speyer C., Lu K. T., Lambris J. D., Zetoune F. S., Ward P. A. Expression and function of C5a receptor in mouse microvascular endothelial cells. J Immunol: 2002; 169 5962 5970
22. Cowan P. J., Robson S. C., d' Apice AJ F. Controlling coagulation dysregulation in xenotransplantation. Curr Opin Organ Transplant: 2011; 16 214 221
23. Iwase H., Ezzelarab M. B., Ekser B., Cooper DK C. The role of platelets in coagulation dysfunction in xenotransplantation, and therapeutic options. Xenotransplantation: 2014; 21 201 220
24. Manly D. A., Boles J., Mackman N. Role of tissue factor in venous thrombosis. Annu Rev Physiol: 2011; 73 515 525
25. Berman D. M., Cabrera O., Kenyon N. M., Miller J., Tam S. H., Khandekar V. S., Picha K. M., Soderman A. R., Jordan R. E., Bugelski P. J., Horninger D., Lark M., Davis J. E., Alejandro R., Berggren P. O., Zimmerman M., O'Neil J. J., Ricordi C., Kenyon N. S. Interference with tissue factor prolongs intrahepatic islet allograft survival in a nonhuman primate marginal mass model. Transplantation: 2007; 84 308 315
26. Ley K., Laudanna C., Cybulsky M. I., Nourshargh S. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol: 2007; 7 678 689
27. Chavakis T. Leucocyte recruitment in inflammation and novel endogenous negative regulators thereof. Eur J Clin Invest: 2012; 42 686 691
28. Langer H. F., Chavakis T. Leukocyte-endothelial interactions in inflammation. J Cell Mol Med: 2009; 13 1211 1220
29. Dalmasso A. P., Platt J. L. Prevention of complement-mediated activation of xenogeneic endothelial cells in an in vitro model of xenograft hyperacute rejection by C1 inhibitor. Transplantation: 1993; 56 1171 1176
30. Risitano A. M., Ricklin D., Huang Y., Reis E. S., Chen H., Ricci P., Lin Z., Pascariello C., Raia M., Sica M., Del Vecchio L., Pane F., Lupu F., Notaro R., Resuello R. R., DeAngelis R. A., Lambris J. D. Peptide inhibitors of C3 activation as a novel strategy of complement inhibition for the treatment of paroxysmal nocturnal hemoglobinuria. Blood: 2014; 123 2094 2101
31. Qu H., Ricklin D., Bai H., Chen H., Reis E. S., Maciejewski M., Tzekou A., DeAngelis R. A., Resuello R. R., Lupu F., Barlow P. N., Lambris J. D. New analogs of the clinical complement inhibitor compstatin with subnanomolar affinity and enhanced pharmacokinetic properties. Immunobiology: 2013; 218 496 505
32. Finch A. M., Wong A. K., Paczkowski N. J., Wadi S. K., Craik D. J., Fairlie D. P., Taylor S. M. Low-molecular-weight peptidic and cyclic antagonists of the receptor for the complement factor C5a. J Med Chem: 1999; 42 1965 1674
33. Saethre M., Schneider MK J., Lambris J. D., Magotti P., Haraldsen G., Seebach J. D., Mollnes T. E. Cytokine secretion depends on Galalpha(1,3)Gal expression in a pig-to-human whole blood model. J Immunol: 2008; 180 6346 6353
34. Spahn J. H., Li W., Kreisel D. Innate immune cells in transplantation. Curr Opin Organ Transplant: 2014; 19 14 19
35. Satyananda V., Hara H., Ezzelarab M. B., Phelps C., Ayares D., Cooper DK C. New concepts of immune modulation in xenotransplantation. Transplantation: 2013; 96 937 945
36. Li K., Zhou W. Anaphylatoxins in organ transplantation. Semin Immunol: 2013; 25 20 28
37. Zhou W. The new face of anaphylatoxins in immune regulation. Immunobiology: 2012; 217 225 234
38. Mitroulis I., Kang Y-Y, Gahmberg C. G., Siegert G., Hajishengallis G., Chavakis T., Choi E. Y. Developmental endothelial locus-1 attenuates complement-dependent phagocytosis through inhibition of Mac-1-integrin. Thromb Haemost: 2014; 111 1004 1006
39. Chavakis E., Choi E. Y., Chavakis T. Novel aspects in the regulation of the leukocyte adhesion cascade. Thromb Haemost: 2009; 102 191 197
40. Hajishengallis G., Chavakis T. Endogenous modulators of inflammatory cell recruitment. Trends Immunol: 2013; 34 1 6
41. Luo B-H, Carman C. V., Springer T. A. Structural basis of integrin regulation and signaling. Annu Rev Immunol: 2007; 25 619 647
42. Kourtzelis I., Markiewski M. M., Doumas M., Rafail S., Kambas K., Mitroulis I., Panagoutsos S., Passadakis P., Vargemezis V., Magotti P., Qu H., Mollnes T. E., Ritis K., Lambris J. D. Complement anaphylatoxin C5a contributes to hemodialysis-associated thrombosis. Blood: 2010; 116 631 639
43. Nilsson B., Larsson R., Hong J., Elgue G., Ekdahl K. N., Sahu A., Lambris J. D. Compstatin inhibits complement and cellular activation in whole blood in two models of extracorporeal circulation. Blood: 1998; 92 1661 1667
44. Nilsson B., Ekdahl K. N., Mollnes T. E., Lambris J. D. The role of complement in biomaterial-induced inflammation. Mol Immunol: 2007; 44 82 94
45. Kourtzelis I., Rafail S., DeAngelis R. A., Foukas P. G., Ricklin D., Lambris J. D. Inhibition of biomaterial-induced complement activation attenuates the inflammatory host response to implantation. FASEB J: 2013; 27 2768 2776
46. Zhang X. F., Feng M. F. Adherence of human monocytes and NK cells to human TNF-alpha-stimulated porcine endothelial cells. Immunol Cell Biol: 2000; 78 633 640
47. Morigi M., Zoja C., Colleoni S., Angioletti S., Imberti B., Donadelli R., Remuzzi A., Remuzzi G. Xenogeneic serum promotes leukocyte-endothelium interaction under flow through two temporally distinct pathways: role of complement and nuclear factor-kappaB. J Am Soc Nephrol: 1999; 10 2197 2207
48. Rollins S. A., Johnson K. K., Li L., Birks C., Matis L. A., Rother R. P. Role of porcine P-selectin in complement-dependent adhesion of human leukocytes to porcine endothelial cells. Transplantation: 2000; 69 1659 1667
49. Robinson L. A., Tu L., Steeber D. A., Preis O., Platt J. L., Tedder T. F. The role of adhesion molecules in human leukocyte attachment to porcine vascular endothelium: implications for xenotransplantation. J Immunol: 1998; 161 6931 6938
50. Banz Y., Cung T., Korchagina E. Y., Bovin N. V., Haeberli A., Rieben R. Endothelial cell protection and complement inhibition in xenotransplantation: a novel in vitro model using whole blood. Xenotransplantation: 2005; 12 434 443
51. Nauseef W. M., Borregaard N. Neutrophils at work. Nat Immunol: 2014; 15 602 611
52. Deban L., Russo R. C., Sironi M., Moalli F., Scanziani M., Zambelli V., Cuccovillo I., Bastone A., Gobbi M., Valentino S., Doni A., Garlanda C., Danese S., Salvatori G., Sassano M., Evangelista V., Rossi B., Zenaro E., Constantin G., Laudanna C., Bottazzi B., Mantovani A. Regulation of leukocyte recruitment by the long pentraxin PTX3. Nat Immunol: 2010; 11 328 334
53. Woodfin A., Voisin M-B, Beyrau M., Colom B., Caille D., Diapouli F-M, Nash G. B., Chavakis T., Albelda S. M., Rainger G. E., Meda P., Imhof B. A., Nourshargh S. The junctional adhesion molecule JAM-C regulates polarized transendothelial migration of neutrophils in vivo. Nat Immunol: 2011; 12 761 769
54. Moberg L., Korsgren O., Nilsson B. Neutrophilic granulocytes are the predominant cell type infiltrating pancreatic islets in contact with ABO-compatible blood. Clin Exp Immunol: 2005; 142 125 131
55. Bongoni A. K., Kiermeir D., Jenni H., Bähr A., Ayares D., Klymiuk N., Wolf E., Voegelin E., Constantinescu M. A., Seebach J. D., Rieben R. Complement dependent early immunological responses during ex vivo xenoperfusion of hCD46/HLA-E double transgenic pig forelimbs with human blood. Xenotransplantation: 2014; 21 230 243
56. Ricklin D., Lambris J. D. Complement in immune and inflammatory disorders: therapeutic interventions. J Immunol: 2013; 190 3839 3847